Marc Bergeron Appointed Vice President, Finance
Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Marc Bergeron to the position of Vice President, Finance, starting April 1, 2020. Mr. Bergeron…
Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Marc Bergeron to the position of Vice President, Finance, starting April 1, 2020. Mr. Bergeron…
As part of the initiatives put forward to find solutions to the COVID-19 pandemic, the Fonds de recherche du Québec and Génome Québec have tasked a group of researchers with…
Given the situation around COVID-19 and actions being taken by the Canadian, Quebec and Ontario governments, the Canada SynBio conference, which was supposed to take place on June 3rd in…
Génome Québec is closely monitoring the development of the situation caused by COVID-19 and has taken all the necessary measures to reduce the risk of transmission. The safety of our…
The budget presented on March 10, by the Minister of Finance, Éric Girard, sends a very encouraging message to the research and innovation community, particularly in life sciences, with many…
Génome Québec will celebrate its 20th anniversary in 2020. To mark the occasion, we are pleased to present our new logo. The logo was developed by taking the double helix,…
Genome Québec is happy to report that Dr. Lucy Gilbert’s research team will receive $ 6.24 million in Genomics Applications Partnership Program (GAPP) funding grant to finalize the development of DOvEEgene…
Mission ADN-eau (Mission eDNA) is a citizen based science project that aims to explore the biodiversity of Quebec water bodies using environmental DNA. More than 500 high school students teamed…
A $3.8 million project puts a New Brunswick company at the forefront of oyster breeding technology in Atlantic Canada. L’Étang Ruisseau Bar (ERB), a New Brunswick oyster seed producer, is…
We are pleased to inform you that Genome Canada has partnered with the Canadian Institutes of Health Research (CIHR) on an ongoing funding call entitled the Canadian 2019 Novel Coronavirus Rapid…